GSA Capital Partners »

Cullinan Oncology shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $104k 10k 10.15

More positions owned by GSA Capital Partners

Progressive Corporation (PGR)
Amazon (AMZN)
Root Cl A New (ROOT)
Meta Platforms Cl A (META)
Monster Beverage Corp (MNST)
UGI Corporation (UGI)
Magnite Ord (MGNI)
John B. Sanfilippo & Son (JBSS)
Dt Midstream Common Stock (DTM)
Weis Markets (WMK)
Apa Corporation (APA)
Appfolio Com Cl A (APPF)
Hims & Hers Health Com Cl A (HIMS)
Zoetis Cl A (ZTS)
Vital Farms (VITL)

View all positions for GSA Capital Partners

Top funds holding Cullinan Oncology

Blue Owl Capital Holdings
Franklin Resources
BVF
Vanguard Group
Braidwell
American International
Nextech Invest
Citadel Advisors
Dimensional Fund Advisors
Tang Capital Management
Deutsche Bank Aktiengesellschaft
OrbiMed Advisors
Charles Schwab Investment Management
Millennium Management
Hudson Bay Capital Management

View all funds holding Cullinan Oncology